Navigation Links
Mounting a multi-layered attack on fungal infections

Unravelling a microbe's multilayer defence mechanisms could lead to effective new treatments for potentially lethal fungal infections in cancer patients and others whose natural immunity is weakened.

Although not as well known as bacterial infections, such as MRSA and E.coli, fungal infections such as that caused by the yeast Candida albicans can be more serious and lead to a higher death rate. Using mutant forms of the C. albicans yeast which lacked different parts of the yeast cell wall, Professor Neil Gow and his colleagues have uncovered a three-pronged mechanism by which the body's immune defences attack the invading fungus.

Presenting the work at the Society for General Microbiology's meeting at Heriot-Watt University, Edinburgh, today (8 September), Professor Gow explained that the yeast's cell wall consists of a skeleton-like structure made up of complex sugars called chitins and glucans, covered by an outer layer of proteins which are highly decorated with sugars. The white blood cells that form part of the human immune system have receptors on their surfaces which recognise specific parts of the yeast cell wall, enabling them to fasten on to the invading yeast cells, kill them and then break them down. However other components in the yeast cell wall were found that can damp down this immune response.

In addition, the immune system needs to attack the glucans in the yeast inner cell wall. In the early stages of infection when the white blood cells start to digest the outer cell wall of the yeast, the glucans become more exposed; the immune system is then able to mount a chemical attack on these molecules.

"We need to find out exactly what the body's immune systems detect and what receptors the defence cells have that recognise the yeast's cell wall components. However, fungi are clever enough to develop evasion strategies so we need to figure what these are too. If we can do this we may be able to stimulate the immune system to work more effectively in killing disease-causing fungi," said Professor Gow.

"In the longer term we may be able to treat patients with immunotherapy with agents that stimulate their immunity - as well as with anti-microbial drugs. In addition our work may also lead to new ways to detect fungal infections earlier. Too often the fungus has taken a hold and established itself so well that treatment becomes even more difficult".


Contact: Dianne Stilwell
Society for General Microbiology

Related biology news :

1. Mounting evidence shows health benefits of grape polyphenols
2. Mounting evidence shows red wine antioxidant kills cancer
3. Study finds women slightly more likely to die than men in the 30 days following a heart attack
4. Early detection and quick response are key to defense against anthrax attack
5. New drug may reduce heart attack damage
6. Heart attacks: The tipping point
7. Yale researchers uncover secrets of salmonellas stealth attack
8. Inhaling a heart attack: How air pollution can cause heart disease
9. Simple test helps predict heart attack risk
10. Shark attacks decline worldwide in midst of economic recession
11. International study identifies gene variants associated with early heart attack
Post Your Comments:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
(Date:10/29/2015)... 2015  The J. Craig Venter Institute (JCVI) policy ... and Biosecurity: Lessons Learned and Options for the Future," ... Human Services guidance for synthetic biology providers has worked ... --> --> Synthetic biology promises ... to pose unique biosecurity threats. It now is easier ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... HILLS, N.J. (PRWEB) , ... November 24, 2015 , ... ... as the recipient of the 2016 USGA Green Section Award. Presented annually since 1961, ... golf through his or her work with turfgrass. , Clarke, of Iselin, ...
(Date:11/24/2015)... Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or ... financial results for the quarter ended September 30, ... Canadian dollars and presented under International Financial Reporting ... ," said Andrew Rae , President ... iCo-008 are not only value enriching for this ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... This fall, ... at competitive events in five states to develop and pitch their BIG ideas to ... from each state are competing for votes to win the title of SAP's Teen ...
Breaking Biology Technology: